Most scientists agree the National Institute of Allergy and Infectious Diseases, one of the 27 branches that make up the National Institutes of Health, faced a difficult decision when it decided to end a coronavirus treatment study early and begin giving remdesivir to patients assigned to receive a placebo after finding that the antiviral drug reduced recovery time. The call has received a lot of support, especially because it was made during a pandemic, and NIAID, considering it a moral imperative, has no regrets, Stat News reports. But there are some holdouts.
Steven Nissen, a trialist and cardiologist at the Cleveland Clinic, and Peter Bach, the director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, don't think recovery time reduction should have been the deciding factor. Instead, they say, the study should have continued until the NIAID was able to collect more data on mortality — the survival rate for coronavirus patients enrolled in the trial wasn't statistically significant when the study ended. "The question is: Was there a route, or is there a route, to determine if the drug can prevent death?," said Nissen.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Why the catastrophe bond market is growingThe Explainer The bonds pay for climate change disaster damages
-
How is the Trump bill changing 529 plans?The Explainer The new bill provides a boost for people pursuing trades and vocational careers or seeking professional licenses and certifications
-
Destination unknown: the exciting ins and outs of mystery travelThe Week Recommends Surprise yourself the next time you vacation
-
'Thriving' ecosystem found 30,000 feet underseaSpeed Read Researchers discovered communities of creatures living in frigid, pitch-black waters under high pressure
-
New York plans first nuclear plant in 36 yearsSpeed Read The plant, to be constructed somewhere in upstate New York, will produce enough energy to power a million homes
-
Dehorning rhinos sharply cuts poaching, study findsSpeed Read The painless procedure may be an effective way to reduce the widespread poaching of rhinoceroses
-
Breakthrough gene-editing treatment saves babyspeed read KJ Muldoon was healed from a rare genetic condition
-
Sea lion proves animals can keep a beatspeed read A sea lion named Ronan beat a group of college students in a rhythmic dance-off, says new study
-
Humans heal much slower than other mammalsSpeed Read Slower healing may have been an evolutionary trade-off when we shed fur for sweat glands
-
Novel 'bone collector' caterpillar wears its preySpeed Read Hawaiian scientists discover a carnivorous caterpillar that decorates its shell with the body parts of dead insects
-
Scientists find hint of alien life on distant worldSpeed Read NASA's James Webb Space Telescope has detected a possible signature of life on planet K2-18b
